Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the Effect of Genetic Variants on Specialized Pro-resolving Mediators and Their Association With Chronic Inflammatory Conditions

NCT04698291 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04698291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the Effect of Genetic Variants on Specialized Pro-resolving Mediators and Their Association With Chronic Inflammatory Conditions
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Recruiting
Start date
May 6, 2021
Completion date
December 8, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, healthy, inflammatory disease